[HTML][HTML] The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly

F Zhang, D Aschenbrenner, JY Yoo, T Zuo - The Lancet Microbe, 2022 - thelancet.com
The gut mycobiome (fungi) is a small but crucial component of the gut microbiome in
humans. Intestinal fungi regulate host homoeostasis, pathophysiological and physiological …

8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients …

AH Groll, D Pana, F Lanternier, A Mesini… - The Lancet …, 2021 - thelancet.com
Paediatric patients with cancer and those undergoing allogeneic haematopoietic cell
transplantation have an increased susceptibility to invasive fungal diseases. In addition to …

Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy

JA Hill, D Li, KA Hay, ML Green… - Blood, The Journal …, 2018 - ashpublications.org
Lymphodepletion chemotherapy with CD19-targeted chimeric antigen receptor–modified T
(CAR-T)-cell immunotherapy is a novel treatment for refractory or relapsed B-cell …

Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology

LR Baden, S Swaminathan, M Angarone… - Journal of the National …, 2016 - jnccn.org
Infectious diseases are important causes of morbidity and mortality in patients with cancer.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and …

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America

AG Freifeld, EJ Bow, KA Sepkowitz… - Clinical infectious …, 2011 - academic.oup.com
This document updates and expands the initial Infectious Diseases Society of America
(IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in …

Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

M Tomblyn, T Chiller, H Einsele, R Gress… - Bone marrow …, 2009 - nature.com
Guidelines for preventing infectious complications among hematopoietic cell transplant
recipients: a global perspective | Bone Marrow Transplantation Skip to main content Thank you …

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

ML Sorror, MB Maris, R Storb, F Baron, BM Sandmaier… - Blood, 2005 - ashpublications.org
We previously reported that the Charlson Comorbidity Index (CCI) was useful for predicting
outcomes in patients undergoing allogeneic hematopoietic cell transplantation (HCT) …

Epidemiology of invasive mycoses in North America

MA Pfaller, DJ Diekema - Critical reviews in microbiology, 2010 - Taylor & Francis
The incidence of invasive mycoses is increasing, especially among patients who are
immunocompromised or hospitalized with serious underlying diseases. Such infections may …

Echinocandin antifungal drugs

DW Denning - The Lancet, 2003 - thelancet.com
The echinocandins are large lipopeptide molecules that are inhibitors of β-(1, 3)-glucan
synthesis, an action that damages fungal cell walls. In vitro and in vivo, the echinocandins …

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

AJ Ullmann, JH Lipton, DH Vesole… - … England Journal of …, 2007 - Mass Medical Soc
Background Invasive fungal infections are an important cause of morbidity and mortality after
allogeneic hematopoietic stem-cell transplantation. Methods In an international …